Eton Pharmaceuticals, Inc. (ETON) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $79.95M | +104.9% |
| 2024 | $39.01M | +23.3% |
| 2023 | $31.64M | +48.9% |
| 2022 | $21.25M | -2.7% |
| 2021 | $21.83M | +55879.5% |
| 2020 | $39.0K | -95.9% |
| 2019 | $959.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $79.95M | +104.9% |
| 2024 | $39.01M | +23.3% |
| 2023 | $31.64M | +48.9% |
| 2022 | $21.25M | -2.7% |
| 2021 | $21.83M | +55879.5% |
| 2020 | $39.0K | -95.9% |
| 2019 | $959.0K | — |